Finance entity
All 1 tracked stories fall under one category: earnings. OptimizeRx Corp. is most often covered alongside Interventional MRI, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 6.3.
Last mentioned: Mar 6, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: earnings. OptimizeRx Corp. is most often covered alongside Interventional MRI, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 6.3. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. OptimizeRx Corp. appears in 1 tracked Finance story from March 6, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 95 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering OptimizeRx Corp.. Shared-story counts are live from our verified record — not editorial picks.
Profound Medical and OptimizeRx reported robust fourth-quarter and full-year 2025 financial results, signaling a significant uptick in the adoption of MRI-guided interventions and digital life sciences engagement. The reports highlight a broader recovery in healthcare technology spending and a shift toward precision-based medical outcomes.
OptimizeRx Corp. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
